As a national medicine shortage worsens, Lipitor (atorvastatin) — a statin medication used to prevent cardiovascular disease in high-risk cases, as well as abnormal lipid levels — has been among hardest to source. Minister of Health and Welfare Hsueh Jui-yuan (薛瑞元) has said that the shortage would not put citizens’ health in jeopardy, as there are other generic drugs that offer the same effect.
The National Health Insurance Administration has been promoting the “same ingredients, same dosage form, same component” policy for years. The problem is that people still fall victim to media hype whenever there are reports of a shortage of a single brand of drug, forcing the government to repeatedly clarify the issue. If people can learn to regard generic drugs as an alternative to brand-name medicines, there would be a lot less confusion and commotion.
The Federation of Taiwan Pharmacists’ Associations once conducted an online poll, with only half of the participants saying they supported the administration’s policy.
Asked if the statement “I would not go the community pharmacy for drugs over concerns that the prescription drug on offer is not a brand-name drug” applied to them, only 40 percent of participants said that they had never had this concern.
Despite pharmacists’ efforts to convince customers that generic drugs are not counterfeit and are alternative medications developed by other companies that offer the same effect as brand-name drugs, people are still unable to shake off their bias and fixed perceptions. This herd mentality not only causes meaningless panic, but hinders Taiwan’s development of generic drugs.
While generic drugs account for the majority of Taiwan’s pharmaceutical manufacturing industry, generics overall account for nearly 70 percent of the quantity, but less than 30 percent of the cost of items covered by the National Health Insurance.
It goes without saying that without demand, local drug companies would not pour more resources into research and development, leaving the generic drug industry to stagnate.
Taiwan became a member of the Pharmaceutical Inspection Convention and Co-operation Scheme in 2015, indicating that Taiwan’s manufactured drugs meet the global standard.
Under the promotion of the Federation of Taiwan Pharmacists’ Associations and the collaboration of hospitals and institutions, most of the refillable prescriptions for patients with chronic illnesses are no longer labeled as “noninterchangeable.”
However, there are still cases in which hospitals have told patients that they have prescribed them “brand-name drugs,” giving people the false impression that they were given medication of superior quality.
Hsueh hit the nail on the head when he said that it is not true when people claim they are not used to generic drugs. Nonetheless, other than relying on pharmacists to teach the public about efficacy of generic medication, the government should create resources and systematically teach the public about generic drugs.
The government should step up its supervision of hospitals. In countries such as Canada, the UK and the US, pharmacists have to list the ingredients of the drug on prescriptions to avoid patients misunderstanding them.
Even though it is a Herculean task to educate the public, peoples’ misconceptions about generic drugs have influenced the drug manufacturing industry and the National Health Insurance system. Only by implementing reforms can the government clear the stigma of generic drugs, enhance the development of the industry and improve citizens’ medication welfare.
Huang Jin-shun is president of the Federation of Taiwan Pharmacists’ Associations.
Translated by Rita Wang
Recently, China launched another diplomatic offensive against Taiwan, improperly linking its “one China principle” with UN General Assembly Resolution 2758 to constrain Taiwan’s diplomatic space. After Taiwan’s presidential election on Jan. 13, China persuaded Nauru to sever diplomatic ties with Taiwan. Nauru cited Resolution 2758 in its declaration of the diplomatic break. Subsequently, during the WHO Executive Board meeting that month, Beijing rallied countries including Venezuela, Zimbabwe, Belarus, Egypt, Nicaragua, Sri Lanka, Laos, Russia, Syria and Pakistan to reiterate the “one China principle” in their statements, and assert that “Resolution 2758 has settled the status of Taiwan” to hinder Taiwan’s
Can US dialogue and cooperation with the communist dictatorship in Beijing help avert a Taiwan Strait crisis? Or is US President Joe Biden playing into Chinese President Xi Jinping’s (習近平) hands? With America preoccupied with the wars in Europe and the Middle East, Biden is seeking better relations with Xi’s regime. The goal is to responsibly manage US-China competition and prevent unintended conflict, thereby hoping to create greater space for the two countries to work together in areas where their interests align. The existing wars have already stretched US military resources thin, and the last thing Biden wants is yet another war.
As Maldivian President Mohamed Muizzu’s party won by a landslide in Sunday’s parliamentary election, it is a good time to take another look at recent developments in the Maldivian foreign policy. While Muizzu has been promoting his “Maldives First” policy, the agenda seems to have lost sight of a number of factors. Contemporary Maldivian policy serves as a stark illustration of how a blend of missteps in public posturing, populist agendas and inattentive leadership can lead to diplomatic setbacks and damage a country’s long-term foreign policy priorities. Over the past few months, Maldivian foreign policy has entangled itself in playing
A group of Chinese Nationalist Party (KMT) lawmakers led by the party’s legislative caucus whip Fu Kun-chi (?) are to visit Beijing for four days this week, but some have questioned the timing and purpose of the visit, which demonstrates the KMT caucus’ increasing arrogance. Fu on Wednesday last week confirmed that following an invitation by Beijing, he would lead a group of lawmakers to China from Thursday to Sunday to discuss tourism and agricultural exports, but he refused to say whether they would meet with Chinese officials. That the visit is taking place during the legislative session and in the aftermath